P59 The utilisation of flow cytology and evaluation of CD4/CD8 ratios from mediastinal and hilar lymph node sampling by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): experiences at oxford university hospitals foundation trust (OUH)

IntroductionEBUS-TBNA is widely used in investigating mediastinal lymphadenopathy of unclear cause and can negate the need for invasive and higher risk procedures such as mediastinoscopy. Mediastinoscopy is still required in non-diagnostic cases and we assessed whether addition of flow cytometry cou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax 2019-12, Vol.74 (Suppl 2), p.A121
Hauptverfasser: Achaiah, A, Lomas, O, Moore, A, Wrightson, J, Sykes, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Suppl 2
container_start_page A121
container_title Thorax
container_volume 74
creator Achaiah, A
Lomas, O
Moore, A
Wrightson, J
Sykes, A
description IntroductionEBUS-TBNA is widely used in investigating mediastinal lymphadenopathy of unclear cause and can negate the need for invasive and higher risk procedures such as mediastinoscopy. Mediastinoscopy is still required in non-diagnostic cases and we assessed whether addition of flow cytometry could add further useful information to standard testingAimCharacterise CD4/CD8 profiles of mediastinal and hilar lymphadenopathy by EBUS–TBNA sampling and flow cytometry.Compare with simultaneous cytology sampling to determine if CD4/CD8 profiles correlate with any particular disease state which may, in cases of uncertainty, assist diagnosis.Methods106 EBUS-derived samples of lymphoid tissue were obtained between October 2015 and October 2018. 85 samples were analysed by flow cytometry and diagnostic cytology. Sampling and analysis was performed in house by OUH. Samples were categorised as either Sarcoid or Not Sarcoid (sub-divided into Lung cancer, Haematological cancer or Non-malignant). Statistical analysis was performed using Mann-Whitney Test for Two Independent Samples.Results3 samples were inadequate for flow cytology and excluded. From histological analysis 44 cases were consistent with Sarcoidosis. 12 lung cancer, 2 haematological malignancy. In 21 cases no malignancy was identified. In 5 of these diagnosis remained uncertain and were kept under observation. Median CD4/CD8 ratio 3.0 (SE ±0.42). In 2 cases EBUS-TBNA sampling was non-diagnostic; diagnosis later confirmed by mediastinoscopy (1 case TB and 1 case Lymphoma). CD4/CD8 profiling not used in diagnosis and therefore did not influence decision to proceed to mediastinoscopy. Table 1 details flow cytometry results.DiscussionOur findings support current literature that CD4/CD8 ratios from EBUS-TBNA sampling of Mediastinal lymph nodes are higher in Sarcoidosis. From our data CD4/CD8 ratios were significantly lower in the Non-sarcoid group. Especially between Lung cancer Vs Sarcoid (p=0.0006) and Non-malignant Vs Sarcoid groups (p=0.007). CD4/CD8 ratios were not significantly different between Lung cancer and Non-malignant groups. Our study is limited by small sample size.ConclusionFlow cytometry profiling of CD4/CD8 ratios from Mediastinal lymph nodes suggested that higher ratios may favour Sarcoid but its utility, at present, is unlikely to be helpful in clinical practice.Abstract P59 Table 1 Diagnosis n Median CD4/CD8 Ratios (SE) Diagnosis by EBUS Mediastinoscopy p value Sarcoid 44 4.0 (±0.47) 44 0 --
doi_str_mv 10.1136/thorax-2019-BTSabstracts2019.202
format Article
fullrecord <record><control><sourceid>proquest_bmj_p</sourceid><recordid>TN_cdi_proquest_journals_2314263994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2314263994</sourcerecordid><originalsourceid>FETCH-LOGICAL-b804-e734032e7ba55920870526ab0e26f38872be531161b0c854ed0fa1802bcd973d3</originalsourceid><addsrcrecordid>eNpdUctu1EAQNAgklsA_tMRlc3AyDz_hlN0EghQRpGzO1tjTXs9qPGNmxsn6xoUf5UvwsihIObW6qrq71BVFS0rOKOXZeeisE_uYEVrGq82dqH1wogn-AJwxwl5GC5pkRcxZmb2KFoQkJM54nr2J3nq_I4QUlOaLF4vvafn7569NhzAGpZUXQVkDtoVW20dopmC13U4gjAR8EHp84teXyfn6sgB3QDy0zvbQo1TCB2WE_jvRKS0c6KkfOjBWInjRD1qZLdQToJG2dtY0nZrlo579ezsaGW9HJVHC3Bv_X2AQpUYQflDuaGJ5tbq_izerbxenHwH3AzqFpkEPIoDdt9ZJGI16QOdVmKCz82QQerZ6uHJcEdzoAyxv769P30Wv25nF9__qSbT5fLVZX8c3t1--ri9u4rogSYw5TwhnmNciTUtGipykLBM1QZa1vChyVmPKKc1oTZoiTVCSVtCCsLqRZc4lP4k-HNcOzv4Y0YdqZ0c3P8xXjNOEZbwsk1n16aiq-101ONULN1WUVIfoq2P01SHp6nn0M8r4H0zYrf4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2314263994</pqid></control><display><type>article</type><title>P59 The utilisation of flow cytology and evaluation of CD4/CD8 ratios from mediastinal and hilar lymph node sampling by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): experiences at oxford university hospitals foundation trust (OUH)</title><source>Alma/SFX Local Collection</source><creator>Achaiah, A ; Lomas, O ; Moore, A ; Wrightson, J ; Sykes, A</creator><creatorcontrib>Achaiah, A ; Lomas, O ; Moore, A ; Wrightson, J ; Sykes, A</creatorcontrib><description>IntroductionEBUS-TBNA is widely used in investigating mediastinal lymphadenopathy of unclear cause and can negate the need for invasive and higher risk procedures such as mediastinoscopy. Mediastinoscopy is still required in non-diagnostic cases and we assessed whether addition of flow cytometry could add further useful information to standard testingAimCharacterise CD4/CD8 profiles of mediastinal and hilar lymphadenopathy by EBUS–TBNA sampling and flow cytometry.Compare with simultaneous cytology sampling to determine if CD4/CD8 profiles correlate with any particular disease state which may, in cases of uncertainty, assist diagnosis.Methods106 EBUS-derived samples of lymphoid tissue were obtained between October 2015 and October 2018. 85 samples were analysed by flow cytometry and diagnostic cytology. Sampling and analysis was performed in house by OUH. Samples were categorised as either Sarcoid or Not Sarcoid (sub-divided into Lung cancer, Haematological cancer or Non-malignant). Statistical analysis was performed using Mann-Whitney Test for Two Independent Samples.Results3 samples were inadequate for flow cytology and excluded. From histological analysis 44 cases were consistent with Sarcoidosis. 12 lung cancer, 2 haematological malignancy. In 21 cases no malignancy was identified. In 5 of these diagnosis remained uncertain and were kept under observation. Median CD4/CD8 ratio 3.0 (SE ±0.42). In 2 cases EBUS-TBNA sampling was non-diagnostic; diagnosis later confirmed by mediastinoscopy (1 case TB and 1 case Lymphoma). CD4/CD8 profiling not used in diagnosis and therefore did not influence decision to proceed to mediastinoscopy. Table 1 details flow cytometry results.DiscussionOur findings support current literature that CD4/CD8 ratios from EBUS-TBNA sampling of Mediastinal lymph nodes are higher in Sarcoidosis. From our data CD4/CD8 ratios were significantly lower in the Non-sarcoid group. Especially between Lung cancer Vs Sarcoid (p=0.0006) and Non-malignant Vs Sarcoid groups (p=0.007). CD4/CD8 ratios were not significantly different between Lung cancer and Non-malignant groups. Our study is limited by small sample size.ConclusionFlow cytometry profiling of CD4/CD8 ratios from Mediastinal lymph nodes suggested that higher ratios may favour Sarcoid but its utility, at present, is unlikely to be helpful in clinical practice.Abstract P59 Table 1 Diagnosis n Median CD4/CD8 Ratios (SE) Diagnosis by EBUS Mediastinoscopy p value Sarcoid 44 4.0 (±0.47) 44 0 -- Not Sarcoid: 38 2.9 (±0.42) 36 2 0.013*, No Malignant cells 21 3.5 (±0.56) 20 1 0.21‡, 0.007† Lung Cancer 12 1.7 (±0.81) 12 0 0.0006* Haematological Cancer 2 -- 1 1 -- P Values (p≤0.05): *; Comparison of CD4/CD8 ratios from Sarcoid with both Not Sarcoid and Lung cancer groups; both comparisons significant. ‡; Lung cancer vs No malignant cells; not significant. †; Comparison of No malignant cells vs Sarcoid; significant.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thorax-2019-BTSabstracts2019.202</identifier><language>eng</language><publisher>London: BMJ Publishing Group LTD</publisher><subject>Cellular biology ; Flow cytometry ; Hematology ; Lung cancer ; Lymphatic system ; Sarcoidosis</subject><ispartof>Thorax, 2019-12, Vol.74 (Suppl 2), p.A121</ispartof><rights>Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Achaiah, A</creatorcontrib><creatorcontrib>Lomas, O</creatorcontrib><creatorcontrib>Moore, A</creatorcontrib><creatorcontrib>Wrightson, J</creatorcontrib><creatorcontrib>Sykes, A</creatorcontrib><title>P59 The utilisation of flow cytology and evaluation of CD4/CD8 ratios from mediastinal and hilar lymph node sampling by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): experiences at oxford university hospitals foundation trust (OUH)</title><title>Thorax</title><description>IntroductionEBUS-TBNA is widely used in investigating mediastinal lymphadenopathy of unclear cause and can negate the need for invasive and higher risk procedures such as mediastinoscopy. Mediastinoscopy is still required in non-diagnostic cases and we assessed whether addition of flow cytometry could add further useful information to standard testingAimCharacterise CD4/CD8 profiles of mediastinal and hilar lymphadenopathy by EBUS–TBNA sampling and flow cytometry.Compare with simultaneous cytology sampling to determine if CD4/CD8 profiles correlate with any particular disease state which may, in cases of uncertainty, assist diagnosis.Methods106 EBUS-derived samples of lymphoid tissue were obtained between October 2015 and October 2018. 85 samples were analysed by flow cytometry and diagnostic cytology. Sampling and analysis was performed in house by OUH. Samples were categorised as either Sarcoid or Not Sarcoid (sub-divided into Lung cancer, Haematological cancer or Non-malignant). Statistical analysis was performed using Mann-Whitney Test for Two Independent Samples.Results3 samples were inadequate for flow cytology and excluded. From histological analysis 44 cases were consistent with Sarcoidosis. 12 lung cancer, 2 haematological malignancy. In 21 cases no malignancy was identified. In 5 of these diagnosis remained uncertain and were kept under observation. Median CD4/CD8 ratio 3.0 (SE ±0.42). In 2 cases EBUS-TBNA sampling was non-diagnostic; diagnosis later confirmed by mediastinoscopy (1 case TB and 1 case Lymphoma). CD4/CD8 profiling not used in diagnosis and therefore did not influence decision to proceed to mediastinoscopy. Table 1 details flow cytometry results.DiscussionOur findings support current literature that CD4/CD8 ratios from EBUS-TBNA sampling of Mediastinal lymph nodes are higher in Sarcoidosis. From our data CD4/CD8 ratios were significantly lower in the Non-sarcoid group. Especially between Lung cancer Vs Sarcoid (p=0.0006) and Non-malignant Vs Sarcoid groups (p=0.007). CD4/CD8 ratios were not significantly different between Lung cancer and Non-malignant groups. Our study is limited by small sample size.ConclusionFlow cytometry profiling of CD4/CD8 ratios from Mediastinal lymph nodes suggested that higher ratios may favour Sarcoid but its utility, at present, is unlikely to be helpful in clinical practice.Abstract P59 Table 1 Diagnosis n Median CD4/CD8 Ratios (SE) Diagnosis by EBUS Mediastinoscopy p value Sarcoid 44 4.0 (±0.47) 44 0 -- Not Sarcoid: 38 2.9 (±0.42) 36 2 0.013*, No Malignant cells 21 3.5 (±0.56) 20 1 0.21‡, 0.007† Lung Cancer 12 1.7 (±0.81) 12 0 0.0006* Haematological Cancer 2 -- 1 1 -- P Values (p≤0.05): *; Comparison of CD4/CD8 ratios from Sarcoid with both Not Sarcoid and Lung cancer groups; both comparisons significant. ‡; Lung cancer vs No malignant cells; not significant. †; Comparison of No malignant cells vs Sarcoid; significant.</description><subject>Cellular biology</subject><subject>Flow cytometry</subject><subject>Hematology</subject><subject>Lung cancer</subject><subject>Lymphatic system</subject><subject>Sarcoidosis</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdUctu1EAQNAgklsA_tMRlc3AyDz_hlN0EghQRpGzO1tjTXs9qPGNmxsn6xoUf5UvwsihIObW6qrq71BVFS0rOKOXZeeisE_uYEVrGq82dqH1wogn-AJwxwl5GC5pkRcxZmb2KFoQkJM54nr2J3nq_I4QUlOaLF4vvafn7569NhzAGpZUXQVkDtoVW20dopmC13U4gjAR8EHp84teXyfn6sgB3QDy0zvbQo1TCB2WE_jvRKS0c6KkfOjBWInjRD1qZLdQToJG2dtY0nZrlo579ezsaGW9HJVHC3Bv_X2AQpUYQflDuaGJ5tbq_izerbxenHwH3AzqFpkEPIoDdt9ZJGI16QOdVmKCz82QQerZ6uHJcEdzoAyxv769P30Wv25nF9__qSbT5fLVZX8c3t1--ri9u4rogSYw5TwhnmNciTUtGipykLBM1QZa1vChyVmPKKc1oTZoiTVCSVtCCsLqRZc4lP4k-HNcOzv4Y0YdqZ0c3P8xXjNOEZbwsk1n16aiq-101ONULN1WUVIfoq2P01SHp6nn0M8r4H0zYrf4</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Achaiah, A</creator><creator>Lomas, O</creator><creator>Moore, A</creator><creator>Wrightson, J</creator><creator>Sykes, A</creator><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201912</creationdate><title>P59 The utilisation of flow cytology and evaluation of CD4/CD8 ratios from mediastinal and hilar lymph node sampling by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): experiences at oxford university hospitals foundation trust (OUH)</title><author>Achaiah, A ; Lomas, O ; Moore, A ; Wrightson, J ; Sykes, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b804-e734032e7ba55920870526ab0e26f38872be531161b0c854ed0fa1802bcd973d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Cellular biology</topic><topic>Flow cytometry</topic><topic>Hematology</topic><topic>Lung cancer</topic><topic>Lymphatic system</topic><topic>Sarcoidosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Achaiah, A</creatorcontrib><creatorcontrib>Lomas, O</creatorcontrib><creatorcontrib>Moore, A</creatorcontrib><creatorcontrib>Wrightson, J</creatorcontrib><creatorcontrib>Sykes, A</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Achaiah, A</au><au>Lomas, O</au><au>Moore, A</au><au>Wrightson, J</au><au>Sykes, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P59 The utilisation of flow cytology and evaluation of CD4/CD8 ratios from mediastinal and hilar lymph node sampling by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): experiences at oxford university hospitals foundation trust (OUH)</atitle><jtitle>Thorax</jtitle><date>2019-12</date><risdate>2019</risdate><volume>74</volume><issue>Suppl 2</issue><spage>A121</spage><pages>A121-</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><abstract>IntroductionEBUS-TBNA is widely used in investigating mediastinal lymphadenopathy of unclear cause and can negate the need for invasive and higher risk procedures such as mediastinoscopy. Mediastinoscopy is still required in non-diagnostic cases and we assessed whether addition of flow cytometry could add further useful information to standard testingAimCharacterise CD4/CD8 profiles of mediastinal and hilar lymphadenopathy by EBUS–TBNA sampling and flow cytometry.Compare with simultaneous cytology sampling to determine if CD4/CD8 profiles correlate with any particular disease state which may, in cases of uncertainty, assist diagnosis.Methods106 EBUS-derived samples of lymphoid tissue were obtained between October 2015 and October 2018. 85 samples were analysed by flow cytometry and diagnostic cytology. Sampling and analysis was performed in house by OUH. Samples were categorised as either Sarcoid or Not Sarcoid (sub-divided into Lung cancer, Haematological cancer or Non-malignant). Statistical analysis was performed using Mann-Whitney Test for Two Independent Samples.Results3 samples were inadequate for flow cytology and excluded. From histological analysis 44 cases were consistent with Sarcoidosis. 12 lung cancer, 2 haematological malignancy. In 21 cases no malignancy was identified. In 5 of these diagnosis remained uncertain and were kept under observation. Median CD4/CD8 ratio 3.0 (SE ±0.42). In 2 cases EBUS-TBNA sampling was non-diagnostic; diagnosis later confirmed by mediastinoscopy (1 case TB and 1 case Lymphoma). CD4/CD8 profiling not used in diagnosis and therefore did not influence decision to proceed to mediastinoscopy. Table 1 details flow cytometry results.DiscussionOur findings support current literature that CD4/CD8 ratios from EBUS-TBNA sampling of Mediastinal lymph nodes are higher in Sarcoidosis. From our data CD4/CD8 ratios were significantly lower in the Non-sarcoid group. Especially between Lung cancer Vs Sarcoid (p=0.0006) and Non-malignant Vs Sarcoid groups (p=0.007). CD4/CD8 ratios were not significantly different between Lung cancer and Non-malignant groups. Our study is limited by small sample size.ConclusionFlow cytometry profiling of CD4/CD8 ratios from Mediastinal lymph nodes suggested that higher ratios may favour Sarcoid but its utility, at present, is unlikely to be helpful in clinical practice.Abstract P59 Table 1 Diagnosis n Median CD4/CD8 Ratios (SE) Diagnosis by EBUS Mediastinoscopy p value Sarcoid 44 4.0 (±0.47) 44 0 -- Not Sarcoid: 38 2.9 (±0.42) 36 2 0.013*, No Malignant cells 21 3.5 (±0.56) 20 1 0.21‡, 0.007† Lung Cancer 12 1.7 (±0.81) 12 0 0.0006* Haematological Cancer 2 -- 1 1 -- P Values (p≤0.05): *; Comparison of CD4/CD8 ratios from Sarcoid with both Not Sarcoid and Lung cancer groups; both comparisons significant. ‡; Lung cancer vs No malignant cells; not significant. †; Comparison of No malignant cells vs Sarcoid; significant.</abstract><cop>London</cop><pub>BMJ Publishing Group LTD</pub><doi>10.1136/thorax-2019-BTSabstracts2019.202</doi></addata></record>
fulltext fulltext
identifier ISSN: 0040-6376
ispartof Thorax, 2019-12, Vol.74 (Suppl 2), p.A121
issn 0040-6376
1468-3296
language eng
recordid cdi_proquest_journals_2314263994
source Alma/SFX Local Collection
subjects Cellular biology
Flow cytometry
Hematology
Lung cancer
Lymphatic system
Sarcoidosis
title P59 The utilisation of flow cytology and evaluation of CD4/CD8 ratios from mediastinal and hilar lymph node sampling by endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): experiences at oxford university hospitals foundation trust (OUH)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T05%3A34%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P59%E2%80%85The%20utilisation%20of%20flow%20cytology%20and%20evaluation%20of%20CD4/CD8%20ratios%20from%20mediastinal%20and%20hilar%20lymph%20node%20sampling%20by%20endobronchial%20ultrasound-guided%20transbronchial%20needle%20aspiration%20(EBUS-TBNA):%20experiences%20at%20oxford%20university%20hospitals%20foundation%20trust%20(OUH)&rft.jtitle=Thorax&rft.au=Achaiah,%20A&rft.date=2019-12&rft.volume=74&rft.issue=Suppl%202&rft.spage=A121&rft.pages=A121-&rft.issn=0040-6376&rft.eissn=1468-3296&rft_id=info:doi/10.1136/thorax-2019-BTSabstracts2019.202&rft_dat=%3Cproquest_bmj_p%3E2314263994%3C/proquest_bmj_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2314263994&rft_id=info:pmid/&rfr_iscdi=true